N-Hydroxy-4-(3-methyl-2-(S)phenyl-butyrylamino)benzamide

N-Hydroxy-4-(3-methyl-2-(S)phenyl-butyrylamino)benzamide
Trade Name
Orphan Indication Schwannoma
USA Market Approval USA
USA Designation Date 2012-01-13 00:00:00
Sponsor Arno Therapeutics, Inc.;200 Route 31 North, Suite 104;Flemington, New Jersey, 08822